inherited liver diseases Flashcards
What are some genetic diseases that can cause liver problems?
Wilson’s disease, alpha-1 antitrypsin deficiency, hereditary hemochromatosis
Alpha-1 antitrypsin deficiency: pathophysiology
A1AT: serine protease inhibitor made in the liver that inhibits neutrophil elastase. A1At deficiency is the result of protein misfolding, which causes the inhibitor to not be secreted. misfolded A1AT is unstable and polymerizes within the liver- eventually causes cirrhosis from accumulation.
A1AT deficiency: genetics
co-dominant inheritance. PiMM normal; PiZZ mutation that usually causes liver disease; PiMZ occasionally have disease to.
can lead to emphysema in the lung.
clinical presentation of A1AT deficiency
biomodal.
neonatal jaundice in 10-15%. Most resolves by itself, but can cause liver failure.
adults: emphysema and abnormal liver enzymes. Or, from compliciations of a crytogenic cirrhosis.
heterozygotes: no disease w/o a trigger, but do show incr. susceptibility to smoking-related emphysema and liver diseases like alcoholic fatty liver, non-alcoholic fatty liver, and hepatitis C.
Dx of A1AT deficiency
evidence of liver or lung dysfunction, AND A1AT deficiency confirmation. usually phenotypic analsysis of A1AT via serum electrophoresis.
liver biopsy: A1AT occlusions after using diastase to clear away starches and staining with PAS. or, stain for A1AT immunohistochemically.
Tx of A1AT deficiency
tell pts to avoid smoking and alcohol. Lung disease: periodic inhaled A1AT. Liver disease: transplant. In the future, maybe drugs that promote autophagy to digest occlusions?
Wilson’s disease genetics and definition.
autosomal recessive disorder of copper excretion that leads to a build up of copper in the liver, brain and kidneys and causes dysfunction.
wilson’s disease pathophysiology
Mutation in ATP-binding protein ATP7B. Effects:
- Prevents biliary excretion of copper: incr. copper in liver to toxic levels. AS liver cells die, it releases copper into the bloodstream.
- Copper in the bloodstream is bad: mutation interfered with the incorporation of free copper into the carrier protein ceruloplasmin. Free copper is deposited in various tissues, where it has a toxic effect.
- Excess copper inhibits IAPs (inhibitor of apoptosis proteins): excess/premature apoptosis and cell destruction.
Clinical presentation of Wilson’s disease
usually before age 40, typically in the 6-20 range.
liver: chronic hepatitis and cirrhosis. may cause acute liver failure with massive hemolysis and acute renal failure, which is usually fatal.
Brain: basal ganglia dysfunction and parkinsonian tremors. neuropsychiatric disease.
Kidney: renal tubular dysfunction
jts: arthritis and degenerative jt disease
Eyes: Kayser Fleisher rings, esp. if CNS is involved.
Wilson’s disease: PE findings; when to suspect it
considered in pts under 40 with:
chronic unexplained liver disease
neuropsychiatric disease with Parkinsonian tremor
or acute hepatic failure.
PE: tremors, stigmata of cirrhosis and portal HTN, eye exam for cataracts and Keiser-Fleisher rings
Wilson’s diseaes: blood test
elevated ALT and AST low serum ceruloplasmin CBC: anemia, and hemolysis features. liver biopsy with an estimation of copper level NO GENETIC TESTING: over 200 mutations
Wilson’s disease: Tx and management
lifelong D penicillamine or trientine hydrochlorid. bind copper from tissue and incr. renal excretion.
Zinc acetate: block intestinal uptake of Cu and promote excretion
Ammonium tetrathiomolybdate: binds free copper from food and in blood and helps rapidly lower copper levels, esp. in pts with neuro sx
Low copper diet: no mushrooms, chocolate, nuts dried fruit, liver, shellfish.
liver transplant if acute liver failure/cirrhosis
Hereditary hemochromatosis: definition and genetics
inherited disorder of iron metab that cuases excessive iron absorption and iron accumitaion leading to organ damage. autosomal recessive with incomplete penetrance. one of the most common genetic diseases of caucasians
pathophysiology of hereditary hemochromatosis
HFE mutation. body can’t regulate dietary iron absorption- acts as though it were constantly iron hungry. Normally, iron in the body upregulates HFE expression. HFE binds beta-2-microglobulin and incr. hepatic production of hepcidin. hepcidin inhibits ferroportin, which moves iron from intestinal epithelial cells to blood. without effective HFE, pts transport iron from the intestine to portal vein even when there is enough iron in the body
Clinical presentation of hereditary hemochromatosis
asymptomatic elevation of transaminases, transferrin saturation, and ferritin level.
Or, nonspecific fatigue, aches and pains, arthralgia.
occasionally presents with cardiomyopathy, hypogonadis, bronze diabetes (cirrhosis, gynecomastia, and bronze skin), or cirrhosis